Blood cancer patients with COVID-19 fare better with convalescent plasma

A new study finds that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival among blood cancer patients hospitalized with the virus. The therapy involves transfusing plasma from people who have recovered from COVID-19 into patients who have leukemia, lymphoma or other blood cancers and are hospitalized with the viral infection.

from Top Health News -- ScienceDaily https://ift.tt/3vynRcN